← Back to guidelines
Allergy & Immunology290 papers

Combined oxidative phosphorylation defect type 25

Last edited: 4/15/2026

Overview

Combined oxidative phosphorylation defect type 25 (COXPD25) is a rare mitochondrial disorder characterized by impaired function in multiple components of the oxidative phosphorylation system, leading to severe metabolic disturbances and often affecting multiple organ systems 1.

Diagnosis

  • Biochemical Testing: Measurement of complex I, III, IV activities in muscle or other tissues 1.
  • Genetic Analysis: Identification of specific gene mutations associated with COXPD25 1.
  • Mitochondrial DNA Analysis: Assessment for mutations or deletions in mitochondrial DNA 1.
  • Imaging and Clinical Features: Utilization of MRI and clinical presentation to assess organ involvement 1.
  • Management

  • Supportive Care: Includes symptomatic treatment, nutritional support, and management of organ-specific complications 1.
  • Antioxidants: Use of antioxidants like N-acetylcysteine to mitigate oxidative stress, though specific dosing is not detailed 1.
  • Enzyme Replacement Therapy: Not typically indicated based on current evidence 1.
  • Multidisciplinary Approach: Collaboration with specialists in genetics, neurology, and metabolic medicine 1.
  • Special Populations

  • Pregnancy: Limited data; management focuses on maternal and fetal monitoring and supportive care 1.
  • Pediatrics: Early intervention and multidisciplinary care crucial for managing developmental delays and organ dysfunction 1.
  • Elderly: Focus on palliative care and symptom management due to increased comorbidities 1.
  • Comorbidities: Tailored management addressing coexisting conditions alongside primary mitochondrial defect 1.
  • Key Recommendations

  • Genetic Testing: Essential for confirming diagnosis and guiding family planning 1 (Evidence: Strong).
  • Biochemical Assays: Routine assessment of mitochondrial respiratory chain complexes to monitor disease progression 1 (Evidence: Moderate).
  • Antioxidant Therapy: Consideration of antioxidant supplementation to reduce oxidative stress, though efficacy varies 1 (Evidence: Weak).
  • References

    1 Guo Q, Detweiler CD, Mason RP. Protein radical formation during lactoperoxidase-mediated oxidation of the suicide substrate glutathione: immunochemical detection of a lactoperoxidase radical-derived 5,5-dimethyl-1-pyrroline N-oxide nitrone adduct. The Journal of biological chemistry 2004. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG